scholarly journals Su1082 The Relationship of Tofacitinib Plasma Concentration to Clinical Efficacy in Ulcerative Colitis Patients in a Dose-Ranging Phase 2 Study

2014 ◽  
Vol 146 (5) ◽  
pp. S-367-S-368 ◽  
Author(s):  
Arnab Mukherjee ◽  
Kaori Ito ◽  
Mike K. Smith ◽  
Chinyu Su ◽  
Wojciech Niezychowski
Keyword(s):  
Ulcerative Colitis ◽  
Plasma Concentration ◽  
Clinical Efficacy ◽  
Phase 2 ◽  
Phase 2 Study ◽  
Dose Ranging ◽  
Relationship Of ◽  
The Relationship

Tu1887 IMPACT OF MIRIKIZUMAB TREATMENT ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ULCERATIVE COLITIS: A PHASE 2 STUDY ANALYSIS USING THE SF-36 V2 STANDARD

2020 ◽  
Vol 158 (6) ◽  
pp. S-1204-S-1205
Author(s):  
Gary R. Lichtenstein ◽  
Brian G. Feagan ◽  
Jay Tuttle ◽  
Nathan Morris ◽  
Yan Dong ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Ulcerative Colitis ◽  
Phase 2 ◽  
Health Related Quality ◽  
Study Analysis ◽  
Sf 36 ◽  
Phase 2 Study ◽  
Related Quality ◽  
Health Related

scholarly journals Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis

2020 ◽  
Vol 158 (3) ◽  
pp. 537-549.e10 ◽  
Author(s):  
William J. Sandborn ◽  
Marc Ferrante ◽  
Bal R. Bhandari ◽  
Elina Berliba ◽  
Brian G. Feagan ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Phase 2 Study ◽  
Randomized Phase 2

scholarly journals Phase 2 Study of CP-690,550, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis

2011 ◽  
Vol 140 (5) ◽  
pp. S-110 ◽  
Author(s):  
William J. Sandborn ◽  
Subrata Ghosh ◽  
Julian Panes ◽  
Ivana Vranic ◽  
Chinyu Su ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Kinase Inhibitor ◽  
Janus Kinase ◽  
Active Ulcerative Colitis ◽  
Phase 2 ◽  
Janus Kinase Inhibitor ◽  
Phase 2 Study

scholarly journals A dose-ranging study of ticagrelor in children aged 3-17 years with sickle cell disease: A 2-part phase 2 study

2018 ◽  
Vol 93 (12) ◽  
pp. 1493-1500 ◽  
Author(s):  
Lewis L. Hsu ◽  
Sharada Sarnaik ◽  
Suzan Williams ◽  
Carl Amilon ◽  
Jenny Wissmar ◽  
...  
Keyword(s):  
Sickle Cell Disease ◽  
Sickle Cell ◽  
Phase 2 ◽  
Cell Disease ◽  
Phase 2 Study ◽  
Dose Ranging

scholarly journals Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study

2018 ◽  
Vol 12 (10) ◽  
pp. 1158-1169 ◽  
Author(s):  
Bruce E Sands ◽  
William J Sandborn ◽  
Brian G Feagan ◽  
Gary R Lichtenstein ◽  
Hongyan Zhang ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Kinase Inhibitor ◽  
Janus Kinase ◽  
Phase 2 ◽  
Janus Kinase Inhibitor ◽  
Severe Ulcerative Colitis ◽  
Phase 2 Study
Sign in / Sign up

Export Citation Format

Share Document